Cloud-clone
SKU:PAB087Hu01
Polyclonal Antibody to Nucleoporin 35kDa (NUP35)
Polyclonal Antibody to Nucleoporin 35kDa (NUP35)
Couldn't load pickup availability
Immunohistochemistry: 5-20µg/mL;1:23-90
Immunocytochemistry: 5-20µg/mL;1:23-90
Optimal working dilutions must be determined by end user.
Product No.
PAB087Hu01
Organism Species
Homo sapiens (Human).
Source
Polyclonal antibody preparation
Host
Rabbit
Potency
n/a
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
None
Immunogen
RPB087Hu01-Recombinant Nucleoporin 35kDa (NUP35)
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Traits
Liquid
Concentration
0.46mg/ml
Organism Species More
n/a
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against NUP35. It has been selected for its ability to recognize NUP35 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.5-2µg/mL;1:230-900
Immunohistochemistry: 5-20µg/mL;1:23-90
Immunocytochemistry: 5-20µg/mL;1:23-90
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPB087Hu01 | Recombinant Nucleoporin 35kDa (NUP35) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB087Hu01 | Polyclonal Antibody to Nucleoporin 35kDa (NUP35) | WB; IHC; ICC; IP. |
Share
